Brief: Humanigen Inc Announces Preparation Of Phase 1B Study OF IFABOTUZUMAB In Solid Tumors

Humanigen

22/10/2021 12:23

Oct 22 (Reuters) - Humanigen Inc  HGEN.O :
    * HUMANIGEN ANNOUNCES PREPARATION OF PHASE 1B STUDY OF
IFABOTUZUMAB IN SOLID TUMORS FOLLOWING PRESENTATION OF PHASE 1
STUDY RESULTS AT EANM‘21
    * HUMANIGEN INC -  PHASE 1B STUDY OF IFABOTUZUMAB IN NON-CNS
SOLID
TUMORS IS PLANNED TO START IN EARLY 2022

Source text for Eikon:  ID:nBwbLZwf6a 
Further company coverage:  HGEN.O